CXXC5 (Retinoid-Inducible Nuclear Factor, RINF) is a Potential Therapeutic Target in High-Risk Human Acute Myeloid Leukemia

Erstveröffentlichung

2013

Authors

Astori, Andrey

Fredly, Hanne

Aloysius, Thomas Aquinas

Bullinger, Lars

Mansat-De Mas, Veronique

et al.

Wissenschaftlicher Artikel

Published in

Oncotarget ; 4 (2013), 9. - S. 1438-1448. - eISSN 1949-2553

Link to publication

https://dx.doi.org/10.18632/oncotarget.1195

Institutions

UKU. Klinik für Innere Medizin III

Subject headings

[Free subject headings]: Acute myeloid leukemia | CXXC5/RINF | chemotherapy | apoptosis | ACUTE MYELOGENOUS LEUKEMIA | STEM-CELL TRANSPLANTATION | AML CELLS | CHROMOSOME-5 ABNORMALITIES | SIGNALING PATHWAY | HEME OXYGENASE-1 | STROMAL CELLS | LENALIDOMIDE | RELEASE
[DDC subject group]: DDC 570 / Life sciences | DDC 610 / Medicine & health

Metadata

Show full item record